The results of this study suggest that there may be an association between piperacillin-tazobactam and vancomycin combination therapy and increased incidence of AKI.

mechanism of resistance, clinical significance, and laboratory detection of hVISA and VISA 7 infections are not conclusive, making it difficult to apply research findings to clinical situations. 8We provide an evidence based review of S. aureus isolates expressing heterogenic and reduced 9 susceptibility to vancomycin. 10